On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients (Q43127390)
Jump to navigation
Jump to search
scientific article published on 15 March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients |
scientific article published on 15 March 2010 |
Statements
1 reference
On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients (English)
1 reference
Wei Cai
1 reference
Qing Xie
1 reference
Baoyan An
1 reference
Hui Wang
1 reference
Xiaqiu Zhou
1 reference
Guomin Zhao
1 reference
Qing Guo
1 reference
Ruiying Gu
1 reference
Shisan Bao
1 reference
15 March 2010
1 reference
1 reference
Identifiers
1 reference